Systematic Review: Faulty Clinical Trial Analyses Favor new toxic drugs
Two important analyses in Open Medicine , a peer-reviewed, independent, open-access journal, focus on methodological flaws in data analysis of randomized drug trials.
Chromium 6_Carcinogen tested in 5 humans in the US
<p> Chromium 6_Carcinogen tested in 5 humans in the US </p> <p> Sat, 8 Nov 2003 </p> <p> Chromium 6 is classified by the Environmental Protection Agency as an “inhalation carcinogen.” Chromium 6 is a by-product of industrial processes and is linked to severe health problems, including lung cancer. No…
Scientific Misconduct Notices
Scientific Misconduct Notices News Stories on Human Research Protection and Commentary by Vera Hassner Sharav April 22, 2002 Scientific misconduct is a big problem undermining the integrity of the scientific literature. Data falsification leads others to erroneous conclusions that may have adverse consequences for patients in clinical research and clinical…
Bitter Pill: NEJM Waited 5 Years to Report Missing Data from published Vioxx Study_WSJ
A documented report by David Armstrong of The Wall Street Journal (below) shatters the last glimmer of illusion about The New England Journal of Medicine as a bastion of scientific and moral integrity.
Medical Journal Editor Finds Truth Hard to Track Down
A front page report in The Wall Street Journal underscores the inherent flaw in the "peer review" vetting system used by science journals.
Oxford Study–No Evidence Flu Vaccine works in infants
USA and Canada’s influenza vaccination programmes for children based on little evidence: The Lancet review of all relevant trials published last winter by Dr. Jefferson and colleagues found no evidence to support the CDC position.
Conflicts of Interest in Clinical Trials
Presented by Vera Hassner Sharav
14th Tri-Service Clinical Investigation Symposium
Sponsored by The U.S. Army Medical Department and The Henry M. Jackson Foundation for the Advancment of Military Medicine
The cornerstone of public trust in medical research is the integrity of academic institutions and the expectation that universities, which rely on public funding, have a responsibility to serve the public good. Financial conflicts of interest affect millions of American people – those who are subjects of clinical trials testing new drugs and those who are prescribed drugs after their approval.
InfoMail for April 22, 2002
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 22, 2002 ScientificMisconduct Notices FYI Scientific misconduct is a big problem undermining theintegrity of the scientific literature. Data falsification leads others toerroneous conclusions that may have…